Industry updates with Dusko Ilic: May 2026

Written by Dusko ILIC
CAR-T Cell therapy Clinical manufacturing Clinical trials FDA Gene therapy Industry developments iPSCs Manufacturing & scale-up Opinion Regulation & policy Report Stem cells

Every month, Dusko Ilic (King's College London; UK) explores the latest breakthroughs and trends shaping the field in his Industry Updates article for our sister journal Regenerative Medicine. Here, he answers three quick-fire questions about the key insights: what did he expect, what surprised him, and what’s the one story we shouldn’t miss? What happened this month that you were expecting? PCSK9 gene editing moves closer to cardiovascular reality One development I was expecting this month was further clinical progress with one-time genetic medicines targeting PCSK9. Eli Lilly (IN, USA) reported positive Phase Ib Heart-2 data for VERVE-102, an investigational in...

To view this content, please register now for access

It's completely free